Retatrutide is an investigational triple receptor agonist acting on GLP-1, GIP, and glucagon receptors currently available only through authorised clinical trials for obesity and type 2 diabetes
Each plan is tailored to your body, your goals, and your response to treatment, creating a path that feels realistic, supportive, and effective
While these were not head-to-head studies, the magnitude of difference has prompted many obesity medicine specialists to include tirzepatide in their treatment algorithms
Waist circumference also dropped more on tirzepatide (-18.4 cm vs -13.0 cm)
Sometimes, the pain may be related to muscular strain or digestive issues like irritable bowel syndrome (IBS)
People being treated with anifrolumab-fnia (Saphnelo) should not receive live vaccines while on this treatment